In the present study, rhPGRN treatment altered the status of upstream components of mTORC1 in cervical mucosa epithelial cells, and enhanced the phosphorylation of mTOR at Ser2448 in cervical cancer and other cancer cell lines, suggesting PGRN-stimulated activation of mTOR signaling is a common phenomenon. The gene discussed is MTOR; the disease is cancer.